Cite
HARVARD Citation
Cho, L. et al. (n.d.). Design and Rationale of the GAUSS‐2 Study Trial: A Double‐Blind, Ezetimibe‐Controlled Phase 3 Study of the Efficacy and Tolerability of Evolocumab (AMG 145) in Subjects With Hypercholesterolemia Who Are Intolerant of Statin Therapy. Clinical cardiology. 37 (3), pp. 131-139. [Online].